PCNA and cancer: Similar to what we observed comparing high vs. low PCNA+ TAMs cases, more M1- than M2-related genes were differentially up-regulated in HR negative tumors vs. HR positive tumors, in high grade vs. low grade tumors, and in patients with no or minimal residual cancer (RCB 0/1) vs. high residual cancer burden (RCB 3).